IPAD-DB ID | C00382 |
Name | Rhinacanthin A |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 5 H 1 4 O 4 |
Molecular Weight | 258.269g/mol |
IUPAC Name | (3R)-3-hydroxy-2, 2-dimethyl-3, 4-dihydrobenzo[g]chromene-5, 10-dione |
InChI | InChI=1S/C15H14O4/c1-15(2)11(16)7-10-12(17)8-5-3-4-6-9(8)13(18)14(10)19-15/h3-6, 11, 16H, 7H2, 1-2H3/t11-/m1/s1 |
InChIKey | ZWWVIPQQWSJFHS-LLVKDONJSA-N |
Canonical SMILES | CC1(C(CC2=C(O1)C(=O)C3=CC=CC=C3C2=O)O)C |
PubChem CID | 44245542 |
DrugBank Accession Number | - |
CAS Registry Number | - |
Molecular Weight(Computed by SwissADME) | 258.27 |
Hac(Computed by SwissADME) | 19 |
Volume(Computed by ADMETlab 2.0) | 261.669 |
Density(Computed by ADMETlab 2.0) | 0.986 |
nRing(Computed by ADMETlab 2.0) | 3 |
MaxRing(Computed by ADMETlab 2.0) | 14 |
nHet(Computed by ADMETlab 2.0) | 4 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 17 |
Flexibility(Computed by ADMETlab 2.0) | 0 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -3.008 |
LogD(Computed by ADMETlab 2.0) | 1.697 |
logP(Computed by ADMETlab 2.0) | 2.582 |
TPSA(Computed by SwissADME) | 63.6 |
Hbond Acceptor(Computed by SwissADME) | 4 |
Hbond Donor(Computed by SwissADME) | 1 |
Rotatable Bonds(Computed by SwissADME) |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | Yes |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.69 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.85 |